tm logo
XCOPRI
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 08 Nov 2024

Last Applicant/ Owned by

Bundang-gu, Seongnam-si,

Gyeonggi-do

KR

13494

Serial Number

87349251 filed on 24th Feb 2017

Registration Number

5426093 registered on 20th Mar 2018

in the Principal Register

Correspondent Address

Diane J. Mason

Diane J. Mason Faegre Drinker Biddle & Reath LLP

San Francisco, CA 94111

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

XCOPRI

Pharmaceutical [ and veterinary ] preparations for treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ sanitary preparations for medical use; ] biological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; biochemical preparations for medical purposes, namely, for the treatment of ce Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical [ and veterinary ] preparations for treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ sanitary preparations for medical use; ] biological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; medical preparation of trace elements for human [ and animal ] use, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ ferments for pharmaceutical purposes; ] biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; [ blood solvent; ] chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; chemical preparations for medical [ or veterinary ] purposes, namely, for the treatment of central nervous system diseases [ , cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; ] therapeutic drugs and agents for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] ; chemico-pharmaceutical preparations for the treatment of central nervous system diseases [ , cancer and metabolic diseases; bacteriological preparations for medical and veterinary use ]


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 87349251

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 255996

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Nov 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08th Nov 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06th Nov 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
16th Aug 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12th Aug 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26th Jan 2024TEAS SECTION 8 & 15 RECEIVED
20th Mar 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04th Sep 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04th Sep 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04th Sep 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED